Telomir Pharmaceuticals, Inc. Signs Media Deal with New to The Street for Network Interview Broadcasts, Billboards, and TV Commercial Support
New to The Street's TV anchors will interview Telomir Pharmaceuticals Inc.'s management team, introducing and discussing the Company's development of its novel TELOMIR-1 drug , designed to affect age reversal.
- New to The Street's TV anchors will interview Telomir Pharmaceuticals Inc.'s management team, introducing and discussing the Company's development of its novel TELOMIR-1 drug , designed to affect age reversal.
- Each filmed segment will air as sponsored programming on Bloomberg TV and the FOX Business Network .
- The New to The Street's social media team and television network partners will re-share media content, creating a platform to increase awareness about TELO.
- New to The Street's TV interviews with Telomir Pharmaceuticals, Inc.'s (NASDAQ: TELO) management, airings as sponsored programming on Bloomberg TV and the Fox Business Network , "To Be Announced."